Paying users zone. Data is covered by 
.
Get to CVS Health Corp. for $15.99, or
get to whole website for at least 3 months from $49.99.
Enterprise Value to EBITDA (EV/EBITDA)
Difficulty: Intermediate
Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
CVS Health Corp., EBITDA calculation
USD $ in millions
| Item | Description | The company |
|---|---|---|
| EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | CVS Health Corp.'s EBITDA increased from 2015 to 2016 but then slightly declined from 2016 to 2017 not reaching 2015 level. |
Enterprise Value to EBITDA Ratio, Current
CVS Health Corp., current EV/EBITDA calculation, comparison to benchmarks
| Selected Financial Data (USD $ in millions) | |
| Enterprise value (EV) | |
| Earnings before interest, tax, depreciation and amortization (EBITDA) | |
| Ratio | |
| EV/EBITDA | |
| Benchmarks | |
| EV/EBITDA, Competitors | |
| Walgreens Boots Alliance Inc. | |
| EV/EBITDA, Sector | |
| Food & Drug Retailers | |
| EV/EBITDA, Industry | |
| Consumer Services | |
If company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
CVS Health Corp., historical EV/EBITDA calculation, comparison to benchmarks
2017 Calculations
3 EV/EBITDA = EV ÷ EBITDA
= ÷ =
| Ratio | Description | The company |
|---|---|---|
| EV/EBITDA | EV/EBITDA is a valuation indicator for the overall company rather than common stock. | CVS Health Corp.'s EV/EBITDA ratio declined from 2015 to 2016 and from 2016 to 2017. |
